Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6736 AL 6750

Modern care for patients with Alzheimer disease: rationale for early intervention

Galluzzi KE, Appelt DM, Balin BJ.

J Am Osteopath Assoc. 2010 Sep;110(9 Suppl 8):S37-42.

Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results

Yaffe K.

JAMA. 2010 Nov 3;304(17):1952-3. doi: 10.1001/jama.2010.1625.

Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease

Small G, Bullock R.

Alzheimers Dement. 2011 Mar;7(2):177-84. doi: 10.1016/j.jalz.2010.03.016. Epub 2010 Nov 5.

[Neuropsychiatric and behavioral symptomatology in Alzheimer disease]

García-Alberca JM, Lara Muñoz JP, Berthier Torres M.

Actas Esp Psiquiatr. 2010 Jul-Aug;38(4):212-22. doi: 10.1016/s0210-4806(10)70045-0. Epub 2010 Jul 1.

Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin

Hamuro A, Saito S.

Psychogeriatrics. 2010 Dec;10(4):198-200. doi: 10.1111/j.1479-8301.2010.00338.x.

Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy

Farlow MR, Grossberg GT, Meng X, Olin J, Somogyi M.

Int J Geriatr Psychiatry. 2011 Dec;26(12):1236-43. doi: 10.1002/gps.2669. Epub 2010 Dec 23.

Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer's Disease

Niziński P, Szalast K, Makuch-Kocka A, Paruch-Nosek K, Ciechanowska M, Plech T.

Molecules. 2026 Jan 16;31(2):320. doi: 10.3390/molecules31020320.

The role of Annexin A2 in Alzheimer's disease: From cellular functions to therapeutic potential

Shu D, Fu C, Liu Z, Li C.

FEBS J. 2026 May 6. doi: 10.1111/febs.70574. Online ahead of print.

Wernicke's encephalopathy unmasking progressive supranuclear palsy and Alzheimer's pathology: a diagnostic challenge in an older adult

Defalque I, Ribeiro Da Costa R, Scheffler M, Mendes A.

BMJ Case Rep. 2026 Jan 6;19(1):e269430. doi: 10.1136/bcr-2025-269430.

Phytoconstituents as Potential Therapeutics against Enzymatic Targets for Neurodegenerative Diseases

Singh H, Pandey VP.

Curr Protein Pept Sci. 2026;27(1):46-65. doi: 10.2174/0113892037350938250514110643.

Resveratrol and the neuroinflammation axis in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cerebral ischemia

Wang H, Li F, Wang H, Tian Z, Fan H, Shi Z.

Front Immunol. 2026 Apr 21;17:1758356. doi: 10.3389/fimmu.2026.1758356. eCollection 2026.

Neuroprotective Effects of Eugenol in Alzheimer's Disease: Mitigating Oxidative Stress, Inflammation and Amyloid Plaques

Kakkar A, Singh H, Anand A, Chopra H, Mishra AK.

Curr Pharm Des. 2026;32(7):493-504. doi: 10.2174/0113816128373290250620054118.

The Ubiquitin-proteasome system in neuroinflammation and neurodegeneration: Molecular insights and therapeutic avenues

Guo Y, Wang N, Tao Z, Huang X, Yu W, Zeng J, Liu X, Chen S, Hua F, Wang X.

Int Immunopharmacol. 2026 Jun 15;179:116599. doi: 10.1016/j.intimp.2026.116599. Epub 2026 Apr 11.

[Acteoside: neurobiological activity spectrum, potential in the treatment of age-associated neurodegenerative diseases]

Berezutsky MA, Andronova TA, Belonogova YV, Durnova NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):41-47. doi: 10.17116/jnevro202612604141.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias